Systematic review / meta-analysis / 2016
Oat β-glucan intake (2.5 to 3.5 g/day for 3 to 8 weeks) significantly lowered fasting plasma glucose and HbA1c in type 2 diabetes patients.
A meta-analysis of four randomized controlled trials evaluated the effects of oat β-glucan (OBG) in 350 patients with type 2 diabetes mellitus. Compared to controls, OBG intake of 2.5 to 3.5 g/day for 3 to 8 weeks significantly lowered fasting plasma glucose by -0.52 mmol/L (95% CI: -0.94, -0.10; p = 0.01) and HbA1c by -0.21% (95% CI: -0.40, -0.02; p = 0.03). However, OBG did not significantly alter fasting plasma insulin concentrations. The authors noted that data regarding the long-term effects of OBG intake on glycaemic control and insulin sensitivity were scarce.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 350 type 2 diabetes mellitus patients across four articles
- What was measured
- Fasting plasma glucose, HbA1c, and fasting plasma insulin
THE PAPER
Effect of Oat β-Glucan Intake on Glycaemic Control and Insulin Sensitivity of Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials.
Shen XL, Zhao T, Zhou Y, Shi X, Zou Y, Zhao G. Nutrients, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.